On October 27, 2023, BioNxt Solutions Inc. closed the transaction. The company issued 2,050,000 common shares at a price of CAD 0.265 per share for gross proceeds of CAD 543,250 in its final tranche for the aggregate gross proceeds of CAD 2,000,750. In connection with closing of the final tranche, the company paid a cash finder's fee in the amount of CAD 43,460 to an eligible finder.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | +11.11% | +1.27% | -17.53% |
Apr. 26 | BioNxt Solutions Inc. Announces ODF Cladribine Update | CI |
Apr. 26 | BioNxt Solutions Inc. announced that it expects to receive CAD 1.62 million in funding | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.53% | 32M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BNXT Stock
- News BioNxt Solutions Inc.
- BioNxt Solutions Inc. announced that it has received CAD 2.00075 million in funding